Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies
Joseph A. Caruso, MyLinh Duong, Jason P.W. Carey, et al.
Cancer Research (2018) Vol. 78, Iss. 19, pp. 5481-5491
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Targeting cell-cycle machinery in cancer
Jan M. Suski, Marcin Braun, Vladislav Strmiska, et al.
Cancer Cell (2021) Vol. 39, Iss. 6, pp. 759-778
Open Access | Times Cited: 379
IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression
Lin Zhang, Yicong Wan, Zihan Zhang, et al.
Theranostics (2020) Vol. 11, Iss. 3, pp. 1100-1114
Open Access | Times Cited: 159
Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability
Rafaela Fagundes, Leonardo K. Teixeira
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 153
cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer
Mengting Chen, Shibo Yu, Tineke van der Sluis, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 18
Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer
Nicole M. Kettner, Smruthi Vijayaraghavan, Merih Güray Durak, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 13, pp. 3996-4013
Open Access | Times Cited: 104
Cyclin E in normal physiology and disease states
Chen Chu, Yan Geng, Yu Zhou, et al.
Trends in Cell Biology (2021) Vol. 31, Iss. 9, pp. 732-746
Open Access | Times Cited: 99
Molecular crosstalk between cancer and neurodegenerative diseases
Jiyeon Seo, Mikyoung Park
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 14, pp. 2659-2680
Open Access | Times Cited: 83
Optimizing therapeutic approaches for HR+/HER2- advanced breast cancer: clinical perspectives on biomarkers and treatment strategies post-CDK4/6 inhibitor progression
J.M. Cejalvo Andujar, Francisco Ayala de la Peña, Mireia Margelí Vila, et al.
Cancer Drug Resistance (2025)
Open Access | Times Cited: 1
Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells
Yanju Wu, Qianqian Zheng, Yan Li, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 68
Structural Insights into Protein Regulation by Phosphorylation and Substrate Recognition of Protein Kinases/Phosphatases
Seung‐Hyeon Seok
Life (2021) Vol. 11, Iss. 9, pp. 957-957
Open Access | Times Cited: 52
E2F1: Cause and Consequence of DNA Replication Stress
Shahd Fouad, David Hauton, Vincenzo D’Angiolella
Frontiers in Molecular Biosciences (2021) Vol. 7
Open Access | Times Cited: 47
The Renaissance of CDK Inhibitors in Breast Cancer Therapy: An Update on Clinical Trials and Therapy Resistance
Mary Abdelmalak, Rajanbir Singh, Mohammed Anwer, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5388-5388
Open Access | Times Cited: 24
Schisandrin B suppresses osteosarcoma lung metastasisin vivoby inhibiting the activation of the Wnt/β‑catenin and PI3K/Akt signaling pathways
Yuping Wang, Jin Chen, Yanran Huang, et al.
Oncology Reports (2022) Vol. 47, Iss. 3
Open Access | Times Cited: 19
RAD52-dependent mitotic DNA synthesis is required for genome stability in Cyclin E1-overexpressing cells
Anastasia Audrey, Yannick P. Kok, Shibo Yu, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114116-114116
Open Access | Times Cited: 4
CDK4/6 Inhibitors: Mechanisms of Resistance and Potential Biomarkers of Responsiveness in Breast Cancer
Bülent Çetin, Chiara A. Wabl, Özge Gümüşay
Future Oncology (2022) Vol. 18, Iss. 9, pp. 1143-1157
Closed Access | Times Cited: 16
Cyclin E1 and cyclin E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targets
Heloisa Milioli, Sarah Alexandrou, Elgene Lim, et al.
Endocrine Related Cancer (2020) Vol. 27, Iss. 5, pp. R93-R112
Open Access | Times Cited: 26
Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration
Xian Chen, Dong Yang, Jason P.W. Carey, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1656-1656
Open Access | Times Cited: 22
Selective CDK4/6 Inhibitors: Biologic Outcomes, Determinants of Sensitivity, Mechanisms of Resistance, Combinatorial Approaches, and Pharmacodynamic Biomarkers
Erik S. Knudsen, Geoffrey I. Shapiro, Khandan Keyomarsi
American Society of Clinical Oncology Educational Book (2020), Iss. 40, pp. 115-126
Open Access | Times Cited: 23
Histopathologic, Genetic and Molecular Characterization of Endometrial Cancer Racial Disparity
Pouya Javadian, Christina Washington, Shylet Mukasa, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1900-1900
Open Access | Times Cited: 20
Research Progress of circRNAs in Head and Neck Cancers
Panchun Li, Kunjie Zhu, Yongzhen Mo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
CELL CYCLE DYSREGULATION IN CANCER
Antonino Glaviano, Samarendra Kumar Singh, E. Hui Clarissa Lee, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 2, pp. 100030-100030
Closed Access | Times Cited: 2
Label‐free cervicovaginal fluid proteome profiling reflects the cervix neoplastic transformation
Natalia Starodubtseva, Alexander G. Brzhozovskiy, Anna E. Bugrova, et al.
Journal of Mass Spectrometry (2019) Vol. 54, Iss. 8, pp. 693-703
Closed Access | Times Cited: 21
Developing a binuclear multi-target Bi(III) complex by optimizing 2-acetyl-3-ethylpyrazine thiosemicarbazides
Muhammad Hamid Khan, Meiling Cai, Shanhe Li, et al.
European Journal of Medicinal Chemistry (2019) Vol. 182, pp. 111616-111616
Closed Access | Times Cited: 18
Long non‐coding RNA MCF2L‐AS1 promotes the aggressiveness of colorectal cancer by sponging miR‐874‐3p and thereby up‐regulating CCNE1
Fakun Huang, Chengying Zheng, Long‐Kai Huang, et al.
The Journal of Gene Medicine (2020) Vol. 23, Iss. 1
Closed Access | Times Cited: 16
N6-methyladenosine (m6A) RNA modification in the pathophysiology of heart failure: a narrative review
Sihan Liu, Tongyu Wang, Zeyi Cheng, et al.
Cardiovascular Diagnosis and Therapy (2022) Vol. 12, Iss. 6, pp. 908-925
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top